Cardiovascular Systems Inc
CSIIDelisted Apr 27, 2023- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001180145
Cardiovascular Systems Inc was delisted on Apr 27, 2023; its insiders filed their last Form 4 on Apr 27, 2023; 150 institutions reported holding it in 13F filings for Q1 2023, worth $766.5M in total; no superinvestor held it.
Key figures
- Insider buys
- 0
- Open market, last 90 days
- Insider sells
- 0
- Open market, last 90 days
- 13F holders
- 150
- Q1 2023, −10 vs. previous quarter
- 13F value
- $766.5M
- Reported value at the end of Q1 2023
- Superinvestors holding
- 0
- At the end of Q1 2023
Superinvestors holding CSII, Q1 2023
No superinvestor reported holding CSII at the end of Q1 2023.
Latest insider trades
Open-market purchases and sales by Cardiovascular Systems Inc insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 23, 2022 (view filing) | May 20 | 3 days | Points Jeffrey S.Chief Financial Officer | PPurchase | +3.00K | $14.50 | +$43.5K | +2.8%109.3K after | |
| May 23, 2022 (view filing) | May 20 | 3 days | Ward Scott R.Chairman and CEO | PPurchase | +3.00K | $14.49 | +$43.5K | +0.5%580.7K after | |
| Feb 24, 2022 (view filing) | Feb 23 | 1 day | Paulsen ErikDirector | PPurchase | +500 | $19.05 | +$9.53K | +250.0%700 after | |
| Feb 9, 2022 (view filing) | Feb 7 | 2 days | Aronson Martha GoldbergDirector | PPurchase | +2.50K | $18.43 | +$46.1K | +33.3%10.0K after | |
| Feb 9, 2022 (view filing) | Feb 7 | 2 days | Robb Rhonda J.Chief Operating Officer | PPurchase | +1.57K | $18.72 | +$29.3K | +1.0%164.1K after | |
| Feb 9, 2022 (view filing) | Feb 8 | 1 day | Points Jeffrey S.Chief Financial Officer | PPurchase | +2.00K | $18.20 | +$36.4K | +2.0%100.8K after | |
| Feb 9, 2022 (view filing) | Feb 7 | 2 days | Ward Scott R.Chairman and CEO | PPurchase | +2.50K | $18.52 | +$46.3K | +0.4%572.2K after |
Top 10 13F holders, Q1 2023
The largest institutional positions in Cardiovascular Systems Inc at the end of Q1 2023; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BlackRock Inc. | 7,176,728 | $142.5M | 0.00% | −719,174−9.1% | Reduced |
| Vanguard Group Inc | 2,954,461 | $58.7M | 0.00% | +109,406+3.8% | Added |
| Brown Capital Management LLC | 2,840,100 | $56.4M | 0.84% | −64,659−2.2% | Reduced |
| Champlain Investment Partners, LLC | 2,301,475 | $45.7M | 0.29% | −36,610−1.6% | Reduced |
| Pentwater Capital Management LP | 1,744,819 | $34.7M | 0.57% | +1,744,819 | New |
| State Street Corp | 1,672,928 | $33.2M | 0.00% | −41,934−2.4% | Reduced |
| Water Island Capital LLC | 1,598,931 | $31.8M | 2.57% | +1,598,931 | New |
| Alpine Associates Management Inc. | 1,448,100 | $28.8M | 1.54% | +1,448,100 | New |
| Neuberger Berman Group LLC | 893,985 | $17.8M | 0.02% | +39,062+4.6% | Added |
| Gabelli Funds LLC | 878,285 | $17.4M | 0.13% | +850,166+3,023.5% | Added |